tiprankstipranks
Nemaura Medical Inc (NMRD)
OTHER OTC:NMRD
US Market

Nemaura Medical (NMRD) Stock Forecast & Price Target

159 Followers
See the Price Targets and Ratings of:

NMRD Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Nemaura
Medical
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

NMRD Stock 12 Month Forecast

There Are No Analyst Ratings for NMRD In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

NMRD Financial Forecast

NMRD Earnings Forecast

Next quarter’s earnings estimate for NMRD is -$0.11 with a range of -$0.11 to -$0.11. The previous quarter’s EPS was ―. NMRD beat its EPS estimate 66.67% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.28% of the time in the same period. In the last calendar year NMRD has Outperformed its overall industry.
Next quarter’s earnings estimate for NMRD is -$0.11 with a range of -$0.11 to -$0.11. The previous quarter’s EPS was ―. NMRD beat its EPS estimate 66.67% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.28% of the time in the same period. In the last calendar year NMRD has Outperformed its overall industry.

NMRD Sales Forecast

Next quarter’s sales forecast for NMRD is $200.00K with a range of $200.00K to $200.00K. The previous quarter’s sales results were ―. NMRD beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 46.71% of the time in the same period. In the last calendar year NMRD has Underperformed its overall industry.
Next quarter’s sales forecast for NMRD is $200.00K with a range of $200.00K to $200.00K. The previous quarter’s sales results were ―. NMRD beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 46.71% of the time in the same period. In the last calendar year NMRD has Underperformed its overall industry.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Ascendiant
$1.5
Buy
3521.88%
Upside
Reiterated
02/21/24
We are adjusting our FY24 estimate for revenue to $0.2 million, from $0.5 million, and for EPS to $(0.32) from $(0.36). Major ME contract and approval: the company received a major provisional order for 17,500 devices and 1.7 million sensors from TPMENA, its MENA (Middle East/North Africa) licensee for its sugarBEAT system. the SFDA (Saudi Authority) approved the sugarBEAT so the formal launch has now started.

Best Analysts Covering Nemaura Medical

Which Analyst Should I Follow If I Want to Buy NMRD and Sell After:
1 Month
Edward WooAscendiant
Success Rate
2/9 ratings generated profit
22%
Average Return
-14.93%
reiterated a buy rating 5 months ago
Copying Edward Woo's trades and holding each position for 1 Month would result in 22.22% of your transactions generating a profit, with an average return of -14.93% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
3 Months
Edward WooAscendiant
Success Rate
2/9 ratings generated profit
22%
Average Return
-24.64%
reiterated a buy rating 5 months ago
Copying Edward Woo's trades and holding each position for 3 Months would result in 22.22% of your transactions generating a profit, with an average return of -24.64% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
1 Year
Edward WooAscendiant
Success Rate
0/9 ratings generated profit
0%
Average Return
-73.00%
reiterated a buy rating 5 months ago
Copying Edward Woo's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -73.00% per trade.
2 Years
Edward WooAscendiant
Success Rate
0/9 ratings generated profit
0%
Average Return
-84.64%
reiterated a buy rating 5 months ago
Copying Edward Woo's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -84.64% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

NMRD Analyst Recommendation Trends

Rating
Aug 23
Sep 23
Dec 23
Jan 24
Feb 24
Strong Buy
4
4
4
3
2
Buy
0
0
0
0
0
Hold
0
0
0
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
4
4
4
3
In the current month, NMRD has received 2 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. NMRD average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

NMRD Stock Forecast FAQ

What is NMRD’s average 12-month price target, according to analysts?
Currently, no data Available
What is NMRD’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for NMRD, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is NMRD a Buy, Sell or Hold?
      Currently, no data Available
      What is Nemaura Medical Inc’s price target?
      Currently, no data Available
      What do analysts say about Nemaura Medical Inc?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of NMRD?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis